Monkey IFN-γ T cell ELISPOT antibody pair - 20-plate

SKU
CT605-20
Validated ELISPOT antibody pair; reagents available separately (1920 determinations).
Species reactivity: rhesus macaque, cynomolgus monkey, pig-tailed macaque, baboon and African green monkey.
Format
20-plate
Price
€ 1,160
Reactivity
Monkey
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Image

References

Authors, et al. Title Journal Year Volume Pages
Ying Feng A replication-incompetent adenovirus type 55 vaccine induces broad and durable protective immunity against pathogenic adenoviruses Mol Ther 2026 34 1597-1615
Yizi He Immune Control of AIDS Progression by an Adenovirus-Based Therapeutic Vaccination in Acute Simian Immunodeficiency Virus-Infected Macaques MedComm (2020) 2025 6 e70309
Sarah Tedjakusuma A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates Vaccines (Basel) 2024 12
Pingchao Li Booster vaccination is required to elicit and maintain COVID-19 vaccine-induced immunity in SIV-infected macaques Emerg Microbes Infect 2023 12 e2136538
Yizi He Arsenic trioxide-induced apoptosis contributes to suppression of viral reservoir in SIV-infected rhesus macaques Microbiol Spectr 2023 11 e0052523
Petra Mooij Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infection Front Immunol 2023 14 1256094
Samantha M Y Chen Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine J Virol 2022 96 e0216121
Petra Mooij Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2 Front Immunol 2022 13 845887
Ariane Volkmann A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques Front Immunol 2022 13 857440
Stefania Capone Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19 Mol Ther 2021 29 2412-2423